https://hepquant.com/hepquant-announces-additions-to-the-executive-leadership-team-to-drive-commercialization/ 2024-10-23T21:10:33+00:00 https://hepquant.com/easl-congress-2023/ 2024-10-23T21:10:33+00:00 https://hepquant.com/wp-content/uploads/2023/06/easl-congress.jpg https://hepquant.com/hepion-pharmaceuticals-phase-2-altitude-nash-trial-achieves-primary-and-secondary-endpoints-including-improvement-in-liver-function-and-multiple-nash-biomarkers/ 2024-10-23T21:10:34+00:00 https://hepquant.com/hepquant-appoints-kelly-r-pitts-ph-d-chief-operating-officer/ 2024-10-23T21:10:34+00:00